Evidence map›Paper›PMID 42704767›Full record

Observational studyEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026

Identifying patients at low risk for atrial fibrillation after cryptogenic stroke: the PAVA score.

Baptiste Maille, Noémie Resseguier, Eloi Marijon, Nathalie Behar, Marc Badoz, Fabrice Vuillier, Cecile Malrain, Claire Grygorowicz, Victor Klein, Aymeric Menet and 8 more

Abstract readMulticenter StudyObservational StudyValidation Study
In one paragraph

Observational study in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Baptiste MailleRhythmology Department, CHU La Timone, 264 Rue Saint-Pierre, 13005 Marseille, France.ORCID 0000-0003-2639-9593
Noémie ResseguierCEReSS-Health Service Research and Quality of Life Center, School of Medicine, Aix-Marseille University, Marseille, France.ORCID 0000-0003-0816-4053
Eloi MarijonDivision of Cardiology, European Georges Pompidou Hospital, Paris, France.ORCID 0000-0001-7227-3428
Nathalie BeharRennes University Hospital, Department of Cardiology, Rennes, France.ORCID 0000-0001-7529-8735
Marc BadozCardiology Department, CHU Besançon, Besançon, France.ORCID 0000-0002-4199-4019
Fabrice VuillierNeurology Department, CHU Besançon, Besançon, France.
Cecile MalrainRennes University Hospital, Department of Neurology, Rennes, France.
Claire GrygorowiczUniversité Bourgogne Europe, CHU Dijon Bourgogne, Service de Cardiologie, EA7460 PEC2, 21000 Dijon, France.
Victor KleinRhythmology Department, CHU La Timone, 264 Rue Saint-Pierre, 13005 Marseille, France.ORCID 0000-0002-5050-2354
Aymeric MenetCardiology Department, Groupe Hospitalier Institut Catholique de Lille, Lille, France.ORCID 0000-0003-4823-1556
Maryam DridiCardiology Department, Groupe Hospitalier Institut Catholique de Lille, Lille, France.ORCID 0009-0000-5905-2591
Christelle HaddadDepartment of Electrophysiology, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 28 avenue du Doyen Lepine, Bron 69500, France.ORCID 0000-0001-6289-0799
David CalvetDepartment of Neurology and Stroke Unit, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Université de Paris Cité, INSERM U1266, Institute of Psychiatry and Neuroscience, Paris, France.
Laurent SuissaDepartment of Neurology and Stroke Unit, CHU La Timone, Marseille, France.
Luciano A SposatoDepartment of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.ORCID 0000-0001-6425-9343
Jean-Claude DeharoRhythmology Department, CHU La Timone, 264 Rue Saint-Pierre, 13005 Marseille, France.ORCID 0000-0002-1534-3845
Yannick BejotUniversité Bourgogne Europe, CHU Dijon Bourgogne, Service de Neurologie , EA7460 PEC2, 21000 Dijon, France.ORCID 0000-0001-7848-7072
Charles GuenanciaUniversité Bourgogne Europe, CHU Dijon Bourgogne, Service de Cardiologie, EA7460 PEC2, 21000 Dijon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsContinuous cardiac monitoring with implantable loop recorders (ILRs) is recommended after cryptogenic stroke to detect occult atrial fibrillation (AF). We aimed to develop and validate a dedicated risk score for AF detection in patients undergoing ILR monitoring after cryptogenic stroke. METHODS AND

resultsThis multicentre study enrolled 1002 consecutive patients (mean age 66.0 ± 12.3 years, 57.9% male) who received an ILR after cryptogenic stroke. The primary outcome was a first episode of AF or atrial tachycardia (AT). A score was developed in a randomly split development cohort and validated internally, accounting for competing risks, missing data imputation, and hazard ratio-based weighting. Among the 668 patients in the development cohort, cumulative incidences of AF/AT at 1, 2, and 3 years were 20.3%, 28.9%, and 33.0%, respectively. Four independent predictors were identified: premature atrial contractions > 200/24 h on Holter-ECG (2 points), age >58-78 years (3 points) or > 78 years (4 points), significant valvular heart disease (1 point), and left atrial dilatation (2 points), forming the PAVA (premature atrial contractions, age, significant valvular heart disease, and left atrial dilatation) score. Discrimination was good in both the development and validation cohorts (c-index 0.73 and 0.79, respectively). The 3-year areas under the curve were 0.800 and 0.905, respectively. A PAVA score ≤ 2, observed in 23.6% of patients, yielded negative predictive values of 89.2% and 100% in the development and validation cohorts. ROC-curve analysis confirmed superior clinical utility over existing scores (Brown ESUS-AF [Brown embolic stroke of undetermined source-atrial fibrillation], HAVOC).

conclusionA PAVA score ≤ 2 demonstrates a high negative predictive value for AF/AT on ILR after cryptogenic stroke, offering a practical tool to optimize patient prioritization for ILR implantation.

Indexed as

Atrial FibrillationDecision Support TechniquesElectrocardiography, AmbulatoryIschemic StrokeStrokeAgedFemaleHumansIncidenceMaleMiddle AgedPredictive Value of TestsReproducibility of ResultsRisk AssessmentRisk FactorsROC CurveAtrial fibrillationCryptogenic strokeESUSPredictionStroke

Identifiers

PMID42704767
PMCPMC13549145

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.